The fibrinolytic system in the newborn: role of histidine-rich glycoprotein.
The fibrinolytic system controls fibrin deposition and its clearance. The efficacy of this system can be evaluated by plasminogen concentration determinations and by the behavior of factors such as histidine-rich glycoprotein (HRG) which controls plasminogen activation and alpha 2-antiplasmin which controls plasmin activity. Circulating plasminogen levels are decreased in the neonatal period. We studied factors affecting fibrinolysis in neonates and observed that an important reduction in HRG accompanied the reduced circulating plasminogen levels, with the result that 85% of circulating plasminogen was not bound to HRG and was thus free for binding to fibrin and for activation to plasmin. This condition is consistent with the increased fibrinolytic activity secondary to the "clotting activation' observed in the neonatal period particularly on the 1st day of life.
Caccamo
M L
ML
Cattedra di Patologia Neonatale, Università Milano, Istituto Ostetrico-Ginecologico L. Mangiagalli, Italy.
Rossi
E
E
Salmoiraghi
M G
MG
Mondonico
P
P
Gianotti
G A
GA
Marini
A
A
D005341:Fibrinolysin / Q000032:analysis / Q000502:physiology; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D007123:Immunoelectrophoresis, Two-Dimensional; D007231:Infant, Newborn / Q000097:blood* / Q000502:physiology; D010958:Plasminogen / Q000032:analysis / Q000502:physiology; D011506:Proteins / Q000502:physiology*; D000979:alpha-2-Antiplasmin / Q000032:analysis / Q000502:physiology; D000099053:Histidine-Rich Glycoprotein
D011506:Proteins; D000979:alpha-2-Antiplasmin; D000099053:Histidine-Rich Glycoprotein; D010958:Plasminogen; D005341:Fibrinolysin